Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Two-faced catalytic autoantibodies.

Paul S.

Blood. 2011 Feb 17;117(7):2084-6. doi: 10.1182/blood-2010-12-324335. No abstract available.

2.

Proteolytic antibodies activate factor IX in patients with acquired hemophilia.

Wootla B, Christophe OD, Mahendra A, Dimitrov JD, Repessé Y, Ollivier V, Friboulet A, Borel-Derlon A, Levesque H, Borg JY, Andre S, Bayry J, Calvez T, Kaveri SV, Lacroix-Desmazes S.

Blood. 2011 Feb 17;117(7):2257-64. doi: 10.1182/blood-2010-07-296103. Epub 2010 Dec 3.

3.

Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.

Otto M.

Annu Rev Microbiol. 2010;64:143-62. doi: 10.1146/annurev.micro.112408.134309. Review.

PMID:
20825344
4.

Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain.

Hifumi E, Higashi K, Uda T.

FEBS J. 2010 Sep;277(18):3823-32. doi: 10.1111/j.1742-4658.2010.07785.x. Epub 2010 Aug 16.

5.

Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.

Paul S, Planque S, Nishiyama Y.

J Clin Immunol. 2010 May;30 Suppl 1:S43-9. doi: 10.1007/s10875-010-9414-5. Review.

6.

Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection.

Planque S, Salas M, Mitsuda Y, Sienczyk M, Escobar MA, Mooney JP, Morris MK, Nishiyama Y, Ghosh D, Kumar A, Gao F, Hanson CV, Paul S.

AIDS. 2010 Mar 27;24(6):875-84. doi: 10.1097/QAD.0b013e3283376e88. Erratum in: AIDS. 2011 Jun 19;25(10):1345-6.

7.

A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein.

Kelker HC, Itri VR, Valentine FT.

PLoS One. 2010 Jan 5;5(1):e8555. doi: 10.1371/journal.pone.0008555.

8.

Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity.

Yang YH, Chang CJ, Chuang YH, Hsu HY, Chen PP, Chiang BL.

Rheumatology (Oxford). 2010 Jan;49(1):34-42. doi: 10.1093/rheumatology/kep328. Epub 2009 Nov 17.

9.

Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.

DeLeo FR, Chambers HF.

J Clin Invest. 2009 Sep;119(9):2464-74. doi: 10.1172/JCI38226. Review.

10.

Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.

Nishiyama Y, Planque S, Mitsuda Y, Nitti G, Taguchi H, Jin L, Symersky J, Boivin S, Sienczyk M, Salas M, Hanson CV, Paul S.

J Biol Chem. 2009 Oct 30;284(44):30627-42. doi: 10.1074/jbc.M109.032185. Epub 2009 Sep 2.

11.

RosettaAntibody: antibody variable region homology modeling server.

Sircar A, Kim ET, Gray JJ.

Nucleic Acids Res. 2009 Jul;37(Web Server issue):W474-9. doi: 10.1093/nar/gkp387. Epub 2009 May 20.

12.

The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300.

Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, Vazquez V, Etienne J, Lina G, Vandenesch F, Bowden MG.

Clin Microbiol Infect. 2009 Feb;15(2):156-64. doi: 10.1111/j.1469-0691.2008.02648.x. Epub 2008 Dec 22.

13.

Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.

Brown EL, Bowden MG, Bryson RS, Hulten KG, Bordt AS, Forbes A, Kaplan SL.

Clin Vaccine Immunol. 2009 Jan;16(1):139-41. doi: 10.1128/CVI.00360-08. Epub 2008 Nov 12.

14.

Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.

Taguchi H, Planque S, Sapparapu G, Boivin S, Hara M, Nishiyama Y, Paul S.

J Biol Chem. 2008 Dec 26;283(52):36724-33. doi: 10.1074/jbc.M806766200. Epub 2008 Oct 30.

15.

PIGS: automatic prediction of antibody structures.

Marcatili P, Rosi A, Tramontano A.

Bioinformatics. 2008 Sep 1;24(17):1953-4. doi: 10.1093/bioinformatics/btn341. Epub 2008 Jul 19.

16.

Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry.

Chen H, Schuster MC, Sfyroera G, Geisbrecht BV, Lambris JD.

J Am Soc Mass Spectrom. 2008 Jan;19(1):55-65. doi: 10.1016/j.jasms.2007.10.009.

17.

Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates.

Bielinska AU, Janczak KW, Landers JJ, Markovitz DM, Montefiori DC, Baker JR Jr.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):271-81. doi: 10.1089/aid.2007.0148.

PMID:
18260780
18.

Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.

Planque S, Mitsuda Y, Taguchi H, Salas M, Morris MK, Nishiyama Y, Kyle R, Okhuysen P, Escobar M, Hunter R, Sheppard HW, Hanson C, Paul S.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1541-54.

PMID:
18160012
19.

Autoantibody-catalyzed hydrolysis of amyloid beta peptide.

Taguchi H, Planque S, Nishiyama Y, Symersky J, Boivin S, Szabo P, Friedland RP, Ramsland PA, Edmundson AB, Weksler ME, Paul S.

J Biol Chem. 2008 Feb 22;283(8):4714-22. Epub 2007 Dec 17.

20.

A structural basis for complement inhibition by Staphylococcus aureus.

Hammel M, Sfyroera G, Ricklin D, Magotti P, Lambris JD, Geisbrecht BV.

Nat Immunol. 2007 Apr;8(4):430-7. Epub 2007 Mar 11.

PMID:
17351618
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk